{"ticker": {"uuid": "e5f3a204-e327-4963-8b3d-719ce16c4dbd", "symbol": "LISN", "name": "Chocoladefabriken Lindt & Spr\u00fcngli AG", "exchange": "EBS", "country": "CH", "sector": "Consumer Defensive", "industry": "Confectioners"}, "articles": [{"title": "Nextensa delivers strong half-year results, supported by several successful transactions", "summary": "Nextensa NV PRESS RELEASE Regulated information Brussels, 12 August 2026, 5:55PM HIGHLIGHTS Nextensadeliversstronghalf-yearresults,supportedbyseveralsuccessful transactions Nextensa achieved strong results in the first half of 2026. The period was marked by several successful transactions, including the sale of Gewerbepark Stadlau in Vienna, the forward sale of The Rock and the sale of B&B Hotels in Cloche d'Or. The granting of the planning and environmental permits for Lake Side in Brussels and the reservation by Vicinity of a substantial residential portion of Bel Towers further underline th", "url": "https://finance.yahoo.com/real-estate/articles/nextensa-delivers-strong-half-results-155500459.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T15:55:00+00:00", "published_display": "12 Aug 2026 15:55", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.267, "duplicate_count": 1, "topics": ["Balance Sheet", "Development", "Dividends", "Financials", "Real Estate", "Transactions"]}, {"title": "Pierre & Vacances-Center Parcs: Total Number of Shares and Voting Rights", "summary": "Pursuant to Article L. 233-8 of the French Commercial Code and Article 223-16 of the General Regulations of the French Autorit\u00e9 des march\u00e9s financiers PARIS, August 12, 2026--(BUSINESS WIRE)--Regulatory News: Pierre & Vacances-Center Parcs (Paris:VAC): Date Number of shares(*) Number of theoretical voting rights Number of actual voting rights (exercisable at General Meetings) (**) 31 July 2026 462 008 714 462 008 714 461 904 805 (*) Ordinary shares only, i.e. excluding 1,130 preferred shares not admitted to trading. (**) Excluding treasury shares, which are deprived of voting rights (the 1,130", "url": "https://finance.yahoo.com/markets/stocks/articles/pierre-vacances-center-parcs-total-133700984.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T13:37:00+00:00", "published_display": "12 Aug 2026 13:37", "sentiment": "positive", "sentiment_pct": 59, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.297, "duplicate_count": 1, "topics": ["Regulation"]}, {"title": "Changes to full-year guidance for BioMar", "summary": "Aktieselskabet Schouw & Co. Today, BioMar has released an announcement with updated guidance for the full year 2026. BioMar now expects revenue in the range of DKK 17-18 billion against previously DKK 16-17 billion and EBIT in the range of DKK 1,200-1,300 million compared to previously DKK 1,100-1,200 million. BioMar constitutes a material part of the portfolio and is fully consolidated into the Schouw & Co. figures, and the information from BioMar will be incorporated into Schouw & Co.'s guidance. Schouw & Co. provides guidance to the market on revenue and EBITDA and will consider its consoli", "url": "https://finance.yahoo.com/markets/stocks/articles/changes-full-guidance-biomar-113300186.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T11:33:00+00:00", "published_display": "12 Aug 2026 11:33", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.164, "duplicate_count": 1, "topics": ["Guidance"]}, {"title": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?", "summary": "The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investmen", "url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T14:30:00+00:00", "published_display": "11 Aug 2026 14:30", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.192, "duplicate_count": 1, "topics": ["Biotech", "Competition", "Earnings", "Fda Approval", "Oncology", "Quarterly Results"]}, {"title": "Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.", "summary": "OSLO, Norway, August 11, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the 'Healthcare Resource Utilization and Costs Associated with Blue Light Versus White Light Cystoscopy in Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study' in JU Open Plus this week. The research objective was to evaluate the economic implications of blue light cystoscopy (BLC\u00ae) versus white light cystoscopy (WLC) with Hexvix\u00ae/Cysview\u00ae in a real-world setting, using claims data from the U.S. Optum Research Database. The study authors described the ba", "url": "https://finance.yahoo.com/healthcare/articles/cost-neutrality-blc-versus-wlc-065700657.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T06:57:00+00:00", "published_display": "11 Aug 2026 06:57", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.181, "duplicate_count": 1, "topics": ["Bladder Cancer", "Diagnostics", "Healthcare"]}, {"title": "Rational AG (RATIY) (Q2 2026) Earnings Call Highlights: Record EBIT Margin and Strategic ...", "summary": "This article first appeared on GuruFocus. Revenue (H1 2026): EUR642 million, up 8% organically and 6% after FX adjustments. Revenue (Q2 2026): EUR324 million, up 4% year-over-year. EBIT (H1 2026): EUR170 million, up 11% year-over-year, with a margin of 26.5% (24.3% excluding tariff refunds). Gross Margin (H1 2026): Improved to 59.8%. Operating Expenses (H1 2026): Increased 5% year-over-year to EUR250 million. iCombi Revenue (H1 2026): EUR562 million, up 5%. iVario Revenue (H1 2026): EUR79 million, up 14%, with North America growing 24%. Germany Revenue (H1 2026): Up 9%. Europe (ex-Germany) Rev", "url": "https://finance.yahoo.com/markets/stocks/articles/rational-ag-ratiy-q2-2026-010402063.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T01:04:02+00:00", "published_display": "11 Aug 2026 01:04", "sentiment": "positive", "sentiment_pct": 78, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.179, "duplicate_count": 1, "topics": ["Earnings", "EBIT Margin", "Growth Rate", "Guidance", "Revenue Growth", "Revenue Growth"]}], "by_tier": {"direct": [{"title": "Nextensa delivers strong half-year results, supported by several successful transactions", "summary": "Nextensa NV PRESS RELEASE Regulated information Brussels, 12 August 2026, 5:55PM HIGHLIGHTS Nextensadeliversstronghalf-yearresults,supportedbyseveralsuccessful transactions Nextensa achieved strong results in the first half of 2026. The period was marked by several successful transactions, including the sale of Gewerbepark Stadlau in Vienna, the forward sale of The Rock and the sale of B&B Hotels in Cloche d'Or. The granting of the planning and environmental permits for Lake Side in Brussels and the reservation by Vicinity of a substantial residential portion of Bel Towers further underline th", "url": "https://finance.yahoo.com/real-estate/articles/nextensa-delivers-strong-half-results-155500459.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T15:55:00+00:00", "published_display": "12 Aug 2026 15:55", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.267, "duplicate_count": 1, "topics": ["Balance Sheet", "Development", "Dividends", "Financials", "Real Estate", "Transactions"]}, {"title": "Pierre & Vacances-Center Parcs: Total Number of Shares and Voting Rights", "summary": "Pursuant to Article L. 233-8 of the French Commercial Code and Article 223-16 of the General Regulations of the French Autorit\u00e9 des march\u00e9s financiers PARIS, August 12, 2026--(BUSINESS WIRE)--Regulatory News: Pierre & Vacances-Center Parcs (Paris:VAC): Date Number of shares(*) Number of theoretical voting rights Number of actual voting rights (exercisable at General Meetings) (**) 31 July 2026 462 008 714 462 008 714 461 904 805 (*) Ordinary shares only, i.e. excluding 1,130 preferred shares not admitted to trading. (**) Excluding treasury shares, which are deprived of voting rights (the 1,130", "url": "https://finance.yahoo.com/markets/stocks/articles/pierre-vacances-center-parcs-total-133700984.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T13:37:00+00:00", "published_display": "12 Aug 2026 13:37", "sentiment": "positive", "sentiment_pct": 59, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.297, "duplicate_count": 1, "topics": ["Regulation"]}, {"title": "Changes to full-year guidance for BioMar", "summary": "Aktieselskabet Schouw & Co. Today, BioMar has released an announcement with updated guidance for the full year 2026. BioMar now expects revenue in the range of DKK 17-18 billion against previously DKK 16-17 billion and EBIT in the range of DKK 1,200-1,300 million compared to previously DKK 1,100-1,200 million. BioMar constitutes a material part of the portfolio and is fully consolidated into the Schouw & Co. figures, and the information from BioMar will be incorporated into Schouw & Co.'s guidance. Schouw & Co. provides guidance to the market on revenue and EBITDA and will consider its consoli", "url": "https://finance.yahoo.com/markets/stocks/articles/changes-full-guidance-biomar-113300186.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T11:33:00+00:00", "published_display": "12 Aug 2026 11:33", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.164, "duplicate_count": 1, "topics": ["Guidance"]}, {"title": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?", "summary": "The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investmen", "url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T14:30:00+00:00", "published_display": "11 Aug 2026 14:30", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.192, "duplicate_count": 1, "topics": ["Biotech", "Competition", "Earnings", "Fda Approval", "Oncology", "Quarterly Results"]}, {"title": "Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.", "summary": "OSLO, Norway, August 11, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the 'Healthcare Resource Utilization and Costs Associated with Blue Light Versus White Light Cystoscopy in Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study' in JU Open Plus this week. The research objective was to evaluate the economic implications of blue light cystoscopy (BLC\u00ae) versus white light cystoscopy (WLC) with Hexvix\u00ae/Cysview\u00ae in a real-world setting, using claims data from the U.S. Optum Research Database. The study authors described the ba", "url": "https://finance.yahoo.com/healthcare/articles/cost-neutrality-blc-versus-wlc-065700657.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T06:57:00+00:00", "published_display": "11 Aug 2026 06:57", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.181, "duplicate_count": 1, "topics": ["Bladder Cancer", "Diagnostics", "Healthcare"]}, {"title": "Rational AG (RATIY) (Q2 2026) Earnings Call Highlights: Record EBIT Margin and Strategic ...", "summary": "This article first appeared on GuruFocus. Revenue (H1 2026): EUR642 million, up 8% organically and 6% after FX adjustments. Revenue (Q2 2026): EUR324 million, up 4% year-over-year. EBIT (H1 2026): EUR170 million, up 11% year-over-year, with a margin of 26.5% (24.3% excluding tariff refunds). Gross Margin (H1 2026): Improved to 59.8%. Operating Expenses (H1 2026): Increased 5% year-over-year to EUR250 million. iCombi Revenue (H1 2026): EUR562 million, up 5%. iVario Revenue (H1 2026): EUR79 million, up 14%, with North America growing 24%. Germany Revenue (H1 2026): Up 9%. Europe (ex-Germany) Rev", "url": "https://finance.yahoo.com/markets/stocks/articles/rational-ag-ratiy-q2-2026-010402063.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T01:04:02+00:00", "published_display": "11 Aug 2026 01:04", "sentiment": "positive", "sentiment_pct": 78, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.179, "duplicate_count": 1, "topics": ["Earnings", "EBIT Margin", "Growth Rate", "Guidance", "Revenue Growth", "Revenue Growth"]}], "industry": [], "sector": []}, "total_fetched": 6, "total_unique": 6, "total_relevant": 6, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 6, "unique_stories": 6, "duplicates_removed": 0, "relevant_stories": 6, "current_evidence": 6, "direct_evidence": 6, "eodhd_articles": 6, "eodhd": {"configured": true, "status": "healthy", "calls_used": 200, "call_budget": 500, "budget_used_pct": 40.0, "requests_made": 40, "last_success_at": "2026-08-13T05:45:20.147420+00:00", "newest_seen_at": "2026-08-13T05:26:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3383, "unmapped_mentions": 1799}, "status": "healthy"}, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 1, "score": 56, "raw_score": 59, "total": 6, "evidence_count": 6, "effective_articles": 5.69, "direct_story_count": 6, "industry_story_count": 0, "sector_story_count": 0, "story_count": 6, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 15, "confidence": 71, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-12T15:55:00+00:00", "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 68, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.8, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.6, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.6, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.6, "count": 1}], "positive_events": 4, "negative_events": 1, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 6, "unique_stories": 6, "duplicates_removed": 0, "relevant_stories": 6, "current_evidence": 6, "direct_evidence": 6, "eodhd_articles": 6, "eodhd": {"configured": true, "status": "healthy", "calls_used": 200, "call_budget": 500, "budget_used_pct": 40.0, "requests_made": 40, "last_success_at": "2026-08-13T05:45:20.147420+00:00", "newest_seen_at": "2026-08-13T05:26:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3383, "unmapped_mentions": 1799}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 96900.0, "latest_week": "2026-08-07", "one_week_move": 2.4, "four_week_move": 2.3, "twelve_week_move": 2.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.272375, "market_dynamics_buy_signal": false, "relative_strength": -21.533081, "fair_value_gap": -9.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.2112, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.4% over one week, +2.3% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 6}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Evidence confidence", "value": "71/100", "tone": "positive", "text": "5.69 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "68/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "15/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.4% over one week, +2.3% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Nextensa delivers strong half-year results, supported by several successful transactions"}], "updated_at": "2026-08-13T05:53:47.486180+00:00", "detail_intelligence": {"headline": "Balanced read", "summary": "Balanced news tone is drawn from 6 fresh independent stories, including 6 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 56, "display": "56", "tone": "neutral", "note": "Balanced news tone"}, {"label": "Evidence confidence", "value": 71, "display": "71", "tone": "positive", "note": "solid confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "6 direct stories"}, {"label": "Evidence agreement", "value": 85, "display": "85", "tone": "positive", "note": "15/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 71, "note": "5.69 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 82, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 85, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 82, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 3, "score": 73, "tone": "positive", "x": 866.4, "y": 93.1, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 3, "score": 49, "tone": "neutral", "x": 912.2, "y": 136.8, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "866.4,93.1 912.2,136.8", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Establishing", "tone": "neutral", "recent_score": 59, "prior_score": null, "delta": null, "recent_count": 6, "prior_count": 0, "volume_delta": 6}, "freshness_buckets": [{"label": "Last 24 hours", "count": 3, "share": 50}, {"label": "1 to 3 days", "count": 3, "share": 50}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 6, "share": 100, "score": 59, "tone": "positive"}], "event_profile": [{"label": "Earnings", "count": 3, "share": 50, "score": 62, "tone": "positive"}, {"label": "Regulatory and legal", "count": 1, "share": 17, "score": 59, "tone": "positive"}, {"label": "Market update", "count": 1, "share": 17, "score": 58, "tone": "positive"}, {"label": "Guidance", "count": 1, "share": 17, "score": 48, "tone": "neutral"}], "topics": [{"label": "Revenue Growth", "count": 2, "share": 33}, {"label": "Guidance", "count": 2, "share": 33}, {"label": "Earnings", "count": 2, "share": 33}, {"label": "Transactions", "count": 1, "share": 17}, {"label": "Regulation", "count": 1, "share": 17}, {"label": "Real Estate", "count": 1, "share": 17}, {"label": "Quarterly Results", "count": 1, "share": 17}, {"label": "Oncology", "count": 1, "share": 17}, {"label": "Healthcare", "count": 1, "share": 17}, {"label": "Growth Rate", "count": 1, "share": 17}], "supporting": [{"label": "Direct evidence", "text": "6 current stories are mapped specifically to LISN."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 85/100, indicating a comparatively coherent tape."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "Nextensa delivers strong half-year results, supported by several successful transactions", "summary": "Nextensa NV PRESS RELEASE Regulated information Brussels, 12 August 2026, 5:55PM HIGHLIGHTS Nextensadeliversstronghalf-yearresults,supportedbyseveralsuccessful transactions Nextensa achieved strong results in the first half of 2026. The period was marked by several successful transactions, including the sale of Gewerbepark Stadlau in Vienna, the forward sale of The Rock and the sale of B&B Hotels in Cloche d'Or. The granting of the planning and environmental permits for Lake Side in Brussels and the reservation by Vicinity of a substantial residential portion of Bel Towers further underline th", "url": "https://finance.yahoo.com/real-estate/articles/nextensa-delivers-strong-half-results-155500459.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T15:55:00+00:00", "published_display": "12 Aug 2026 15:55", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.269, "duplicate_count": 1, "topics": ["Balance Sheet", "Development", "Dividends", "Financials", "Real Estate", "Transactions"]}, "article_count": 6, "updated_at": "2026-08-13T04:35:49.514834+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 79.9, "label": "13 Feb 2026", "close": 120734.2, "index": 100.0}, {"x": 78.6, "y": 55.8, "label": "20 Feb 2026", "close": 126043.36, "index": 104.4}, {"x": 115.3, "y": 62.0, "label": "27 Feb 2026", "close": 124666.91, "index": 103.3}, {"x": 151.9, "y": 79.9, "label": "06 Mar 2026", "close": 120734.2, "index": 100.0}, {"x": 188.5, "y": 109.3, "label": "13 Mar 2026", "close": 114245.23, "index": 94.6}, {"x": 225.2, "y": 144.0, "label": "20 Mar 2026", "close": 106576.45, "index": 88.3}, {"x": 261.8, "y": 129.8, "label": "27 Mar 2026", "close": 109722.62, "index": 90.9}, {"x": 298.4, "y": 124.4, "label": "03 Apr 2026", "close": 110902.43, "index": 91.9}, {"x": 335.1, "y": 140.0, "label": "10 Apr 2026", "close": 107461.3, "index": 89.0}, {"x": 371.7, "y": 150.3, "label": "17 Apr 2026", "close": 105200.0, "index": 87.1}, {"x": 408.3, "y": 164.8, "label": "24 Apr 2026", "close": 102000.0, "index": 84.5}, {"x": 445.0, "y": 169.8, "label": "01 May 2026", "close": 100900.0, "index": 83.6}, {"x": 481.6, "y": 184.7, "label": "08 May 2026", "close": 97600.0, "index": 80.8}, {"x": 518.2, "y": 197.4, "label": "15 May 2026", "close": 94800.0, "index": 78.5}, {"x": 554.9, "y": 190.1, "label": "22 May 2026", "close": 96400.0, "index": 79.8}, {"x": 591.5, "y": 194.2, "label": "29 May 2026", "close": 95500.0, "index": 79.1}, {"x": 628.2, "y": 193.8, "label": "05 Jun 2026", "close": 95600.0, "index": 79.2}, {"x": 664.8, "y": 199.7, "label": "12 Jun 2026", "close": 94300.0, "index": 78.1}, {"x": 701.4, "y": 204.2, "label": "19 Jun 2026", "close": 93300.0, "index": 77.3}, {"x": 738.1, "y": 187.0, "label": "26 Jun 2026", "close": 97100.0, "index": 80.4}, {"x": 774.7, "y": 181.5, "label": "03 Jul 2026", "close": 98300.0, "index": 81.4}, {"x": 811.3, "y": 197.8, "label": "10 Jul 2026", "close": 94700.0, "index": 78.4}, {"x": 848.0, "y": 180.6, "label": "17 Jul 2026", "close": 98500.0, "index": 81.6}, {"x": 884.6, "y": 203.7, "label": "24 Jul 2026", "close": 93400.0, "index": 77.4}, {"x": 921.2, "y": 198.3, "label": "31 Jul 2026", "close": 94600.0, "index": 78.4}, {"x": 957.9, "y": 187.9, "label": "07 Aug 2026", "close": 96900.0, "index": 80.3}], "sentiment_points": [{"x": 711.2, "y": 131.8, "label": "20 Jun 2026", "score": 49}, {"x": 722.4, "y": 131.8, "label": "23 Jun 2026", "score": 49}, {"x": 723.1, "y": 131.8, "label": "23 Jun 2026", "score": 49}, {"x": 739.0, "y": 131.8, "label": "26 Jun 2026", "score": 49}, {"x": 749.2, "y": 130.0, "label": "28 Jun 2026", "score": 50}, {"x": 753.6, "y": 130.0, "label": "28 Jun 2026", "score": 50}, {"x": 765.3, "y": 131.8, "label": "01 Jul 2026", "score": 49}, {"x": 772.5, "y": 133.7, "label": "02 Jul 2026", "score": 48}, {"x": 772.9, "y": 131.8, "label": "02 Jul 2026", "score": 49}, {"x": 775.4, "y": 131.8, "label": "03 Jul 2026", "score": 49}, {"x": 792.5, "y": 130.0, "label": "06 Jul 2026", "score": 50}, {"x": 797.9, "y": 131.8, "label": "07 Jul 2026", "score": 49}, {"x": 823.2, "y": 133.7, "label": "12 Jul 2026", "score": 48}, {"x": 841.7, "y": 130.0, "label": "15 Jul 2026", "score": 50}, {"x": 859.1, "y": 128.2, "label": "19 Jul 2026", "score": 51}, {"x": 864.4, "y": 128.2, "label": "20 Jul 2026", "score": 51}, {"x": 867.4, "y": 130.0, "label": "20 Jul 2026", "score": 50}, {"x": 875.2, "y": 117.1, "label": "22 Jul 2026", "score": 57}, {"x": 875.4, "y": 119.0, "label": "22 Jul 2026", "score": 56}, {"x": 877.5, "y": 119.0, "label": "22 Jul 2026", "score": 56}, {"x": 880.4, "y": 119.0, "label": "23 Jul 2026", "score": 56}, {"x": 880.9, "y": 119.0, "label": "23 Jul 2026", "score": 56}, {"x": 881.6, "y": 119.0, "label": "23 Jul 2026", "score": 56}, {"x": 884.7, "y": 119.0, "label": "24 Jul 2026", "score": 56}, {"x": 907.7, "y": 131.8, "label": "28 Jul 2026", "score": 49}, {"x": 922.3, "y": 131.8, "label": "31 Jul 2026", "score": 49}, {"x": 932.8, "y": 130.0, "label": "02 Aug 2026", "score": 50}, {"x": 944.4, "y": 130.0, "label": "04 Aug 2026", "score": 50}, {"x": 958.0, "y": 128.2, "label": "07 Aug 2026", "score": 51}], "price_path": "42.0,79.9 78.6,55.8 115.3,62.0 151.9,79.9 188.5,109.3 225.2,144.0 261.8,129.8 298.4,124.4 335.1,140.0 371.7,150.3 408.3,164.8 445.0,169.8 481.6,184.7 518.2,197.4 554.9,190.1 591.5,194.2 628.2,193.8 664.8,199.7 701.4,204.2 738.1,187.0 774.7,181.5 811.3,197.8 848.0,180.6 884.6,203.7 921.2,198.3 957.9,187.9", "sentiment_path": "711.2,131.8 722.4,131.8 723.1,131.8 739.0,131.8 749.2,130.0 753.6,130.0 765.3,131.8 772.5,133.7 772.9,131.8 775.4,131.8 792.5,130.0 797.9,131.8 823.2,133.7 841.7,130.0 859.1,128.2 864.4,128.2 867.4,130.0 875.2,117.1 875.4,119.0 877.5,119.0 880.4,119.0 880.9,119.0 881.6,119.0 884.7,119.0 907.7,131.8 922.3,131.8 932.8,130.0 944.4,130.0 958.0,128.2", "price_change": -19.7, "sentiment_change": 2, "latest_close": 96900.0, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}